


Pediatric Neurology, Part I, Volume 111
Dulac, O.
ISBN-13: 9780444528919
ELSEVIER
Junio / 2013
1ª Edición
Inglés
Tapa dura
892 pags
2697 gr
20 x 27 x 5 cm
Recíbelo en un plazo De 7 a 10 días
Description
The child is neither an adult miniature nor an immature human being: at each
age, it expresses specific abilities that optimize adaptation to its environment
and development of new acquisitions. Diseases in children cover all specialties
encountered in adulthood, and neurology involves a particularly large area,
ranging from the brain to the striated muscle, the generation and functioning
of which require half the genes of the whole genome and a majority of mitochondrial
ones. Human being nervous system is sensitive to prenatal aggression, is particularly
immature at birth and development may be affected by a whole range of age-dependent
disorders distinct from those that occur in adults. Even diseases more often
encountered in adulthood than childhood may have specific expression in the
developing nervous system. The course of chronic neurological diseases beginning
before adolescence remains distinct from that of adult pathology – not
only from the cognitive but also motor perspective, right into adulthood, and
a whole area is developing for adult neurologists to care for these children
with persisting neurological diseases when they become adults.
Just as pediatric neurology evolved as an identified specialty as the volume
and complexity of data became too much for the general pediatician or the adult
neurologist to master, the discipline has now continued to evolve into so many
subspecialties, such as epilepsy, neuromuscular disease, stroke, malformations,
neonatal neurology, metabolic diseases, etc., that the general pediatric neurologist
no longer can reasonably possess in-depth expertise in all areas, particularly
in dealing with complex cases. Subspecialty expertise thus is provided to some
trainees through fellowship programmes following a general pediatric neurology
residency and many of these fellowships include training in research.
Since the infectious context, the genetic background and medical practice vary
throughout the world, this diversity needs to be represented in a pediatric
neurology textbook. Taken together, and although brain malformations (H. Sarnat
& P. Curatolo, 2007) and oncology (W. Grisold & R. Soffietti) are covered
in detail in other volumes of the same series and therefore only briefly addressed
here, these considerations justify the number of volumes, and the number of
authors who contributed from all over the world. Experts in the different subspecialties
also contributed to design the general framework and contents of the book. Special
emphasis is given to the developmental aspect, and normal development is reminded
whenever needed – brain, muscle and the immune system. The course of chronic
diseases into adulthood and ethical issues specific to the developing nervous
system are also addressed.
Table of Contents
SECTION 1 GENERAL INTRODUCTION
1. Normal psychomotor development - G. Cioni and G. Sgandurra (Pisa, Italy)
2. Clinical neurological examination of infants and children - R.H.A. Haslam
(Toronto, Canada)
3. Pediatric neurology - the diagnostic process - B.G.R. Neville (London, UK)
4. Health outcomes measurement: concepts, guidelines and opportunities - G.M.
Ronen and P.L. Rosenbaum (Hamilton, Canada)
5. Coma - F.J. Kirkham and S. Ashwal (London, UK and Loma Linda, USA)
6. Clinical and imaging diagnosis for heredodegenerative diseases - N. Boddaert,
F. Brunelle and I. Desguerre (Paris, France)
7. Developmental aspects of normal EEG - P. Plouin, A. Kaminska, M-L. Moutard
and C. Soufflet (Paris, France)
8. Clinical neurophysiology in movement disorders - E. Apartis (Paris, France)
9. Announcing the diagnosis: counselling the parents - D. Taylor and P. Le Coz
(London, UK and Marseilles, France)
10. Chronic paediatric diseases into adulthood and the challenge of adolescence
- D. Sommelet (Vandoeuvre Les Nancy, France)
11. Ethical considerations in pediatric neurology - G.M. Ronen and B. Dan (Hamilton,
Canada and Brussels, Belgium)
SECTION 2 TOXIC AND DEFICIENCY, FETOPATHIES
12. Neuroembryology and brain malformations: an overview - H.B. Sarnat and L.
Flores-Sarnat (Calgary, Canada)
13. Microcephaly - S. Passemard, A. Verloes and A.M. Kaindl (Paris, France and
Berlin, Germany)
14. Prenatal-onset neurodevelopmental disorders secondary to toxins, nutritional
deficiencies and maternal illness - W.D. Graf, M.V. Kekatpure and B.E. Kosofsky
(Kansas City and New York, USA)
SECTION 3 CEREBRAL PALSY
15. Epidemiology of cerebral palsy - K. Himmelmann (Göteborg, Sweden)
16. Pathophysiology of cerebral palsy - S. Marret, C. Vanhulle and A. Laquerriere
(Rouen, France)
17. Imaging cerebral palsy - M. Staudt (Tübingen, Germany)
18. Cerebral palsy: definition, assessment and rehabilitation - C.L. Richards
and F. Malouin (Quebec, Canada)
19. Treatment of movement disorders in dystonia-choreoathtosis cerebral palsy
- M. Vidailhet (Paris, France)
20. Everyday life and social consequences of cerebral palsy - P. Uldall (Blegdamsvej,
Denmark)
SECTION 4 DEVELOPMENTAL ABNORMALITIES AND MENTAL RETARDATION
21. Developmental abnormalıtıes and mental retardatıon:
diagnostıc strategy - M. Topcu and D. YalnizoÄ?lu (Ankara,
Turkey)
22. Specific language impairment - A.G. Kamhi and M.K. Clark (Greensboro, USA)
23. Dyslexia - M. Habib and K. Giraud (Marseilles, France)
24. Congenital Amusia - V.J. Williamson and L. Stewart (London, UK)
25. Developmental dyscalculia - G.R. Price and D. Ansari (London, Canada)
26. Nonverbal learning disability - J. Volden (Edmonton, Canada)
27. Memory disorders in children - S. Majerus and M. van der Linden (Liège
and Brussels, Belgium and Geneva, Switzerland)
28. Attention deficit - D.W. Dunn and W.G. Kronenberger (Indianapolis, USA)
29. The autistic spectrum - L. Mottron and M. Dawson (Montreal, Canada)
30. Cognitive and medical features of chromosomal neuploidy - C. Hutaff-Lee,
L. Cordeiro and N. Tartaglia (Aurora, USA)
31. Genetically determined encephalopathy: Rett syndrome - N. Bahi-Buisson (Paris,
France)
32. Angelman syndrome - M. Kyllerman (Gothenberg, Sweden)
33. Developmental and cognitive troubles in Williams Syndrome - M. Martens (Newark,
USA)
34. Smith Magenis syndrome - H. de Leersnyder (Paris, France)
35. X-linked mental deficiency - V. des Portes (Lyon, France)
SECTION 5 NEUROECTODERMOSES
36. Genetics of neural crest and neurocutaneous syndromes - H.B. Sarnat and
L. Flores-Sarnat (Calgary, Canada)
37. Sturge-Weber syndrome - R. Nabbout and C. Juhász (Paris, France
and Detroit, USA)
38. Tuberous sclerosis - P. Curatolo and B.L. Maria (Rome, Italy and Augusta,
USA)
39. Neurofibromatosis - B.R. Korf (Birmingham, USA)
40. Incontinentia pigmenti and hypomelanosis of Ito - C. Bodemer (Paris, France)
41. Epidermal nevus syndrome - L. Flores-Sarnat (Calgary, Canada)
42. Neurocutaneous melanocytosis - L. Flores-Sarnat (Calgary, Canada)
SECTION 6 EPILEPSY
43. The epidemiology of seizure disorders in infancy and childhood: definitions
and Classifications - A.T. Berg, P. Jallon and P.M. Preux (Chicago, US; Geneva,
Switzerland and Limoges, France)
44. Neuropathology of paediatric epilepsy - H.B. Sarnat and L. Flores-Sarnat
(Calgary, Canada)
45. The developing cortex - Y. Ben-Ari and R. Khazipov (Marseille, France)
46. Epileptogenesis in the developing brain - C.G. Wasterlain, D.S. Gloss, J.
Niquet and A.S. Wasterlain (Los Angeles, USA)
47. Brain maturation and epilepsy - O. Dulac, M. Milh and G.L. Holmes (Paris
and Marseille, France and Lebanon, USA)
48. Modes of onset of epilepsy and differential diagnosis - P. Camfield and
C. Camfield (Halifax, Canada)
49. Varying seizure semiology according to age - D.R. Nordli (Chicago, USA)
50. Magnetoencephalography (MEG) and other neurophysiological investigations
- R. Paetau and I.S. Mohamed (Helsinki, Finland and Calgary, Canada)
51. Neonatal seizures - P.Plouin and A. Kaminska (Paris, France)
52. Febrile and other occasional seizures - T. Bast and L. Carmant (Kehl, Germany
and Montreal, Canada)
53. Focal epileptogenic lesions - A.N.V. Moosa and E. Wyllie (Cleveland, USA)
54. Rasmussenâ??s encephalitis - T. Granata and F. Andermann (Milan, Italy
and Montreal, Canada)
55. Immune-mediated paediatric epilepsies - C.G. Bien and A. Vincent (Bonn,
Germany and Oxford, UK)
56. Inborn errors of metabolism and epilepsy - N. Bahi-Buisson and O. Dulac
(Paris, France)
57. Chromosome disorders associated with epilepsy - S.M. Zuberi (Glasgow, UK)
58. Focal malformations of cortical development: a most relevant etiology of
epilepsy in Children - A. Palmini and H. Holtshausen (Porto Alegre, Brazil and
Vogtareuth, Germany)
59. Genetics of idiopathic epilepsies - R. Nabbout and I.E. Scheffer (Paris,
France and Melbourne, Australia)
60. Idiopathic generalized epilepsies - R.H. Caraballo and B. Dalla Bernadina
(Buenos Aires, Argentina and Verona, Italy)
61. Idiopathic focal epilepsies - F. Vigevano, N. Specchio and N. Fejerman (Rome,
Italy and Buenos Aires, Argentina)
62. Malignant migrating partial seizures in infancy - G. Coppola (Salerno, Italy)
63. Infantile spasms - R.A. Hrachovy and J.D. Frost Jr. (Houston, USA)
64. The epileptic encephalopathies - J.H. Cross and R. Guerrini (London and
Lingfield, UK and Florence, Italy)
65. Dravet syndrome (severe myoclonic epilepsy in infancy) - C. Dravet and H.
Oguni (Rome, Italy and Tokyo, Japan)
66. Epileptic encephalopathy with continuous spike-waves during slow-wave sleep
including Landau-Kleffner syndrome - P. van Bogaert (Brussels, Belgium)
67. Lennox-Gastaut syndrome and epilepsy with myoclonic-astatic seizures - A.
Kaminska and H. Oguni (Paris, France and Tokyo, Japan)
68. Diffuse malformations of cortical development - N. Bahi-Buisson and R. Guerrini
(Paris, France and Florence, Italy)
69. Myoclonus and epilepsy - R. Guerrini and T. Takahashi (Florence, Italy and
Tokyo, Japan)
70. Status epilepticus - O. Dulac and T. Takahashi (Paris, France and Tokyo,
Japan)
71. Cognitive disorders in paediatric epilepsy - I. Jambaqué, C.
Pinabiaux and M. Lassonde (Paris, France and Montreal, Canada)
72. Problematic behaviour in children with epilepsy: issues and management -
D. Taylor and F. Besag (London, UK)
73. Cognitive side-effects of antiepileptic drugs in children - D.M. Ijff and
A.P. Aldenkamp (Heeze and Maastricht, The Netherlands)
74. Initiating antiepileptic drug treatment and characteristics of drugs - B.F.D.
Bourgeois (Boston, USA)
75. Treatment strategies - C. Chiron and M. Duchowny (Paris, France and Miami,
USA)
76. Developing antiepileptic drugs in children: balancing protection and access
- J-P. Amann, T. Glauser and C. Chiron (Paris, France and Cincinnati, USA)
77. Structural imaging in children with chronic focal epilepsy: exploration
strategies and
diagnostic algorithms - F.G. Woermann and G. Vézina (Bielefeld,
Germany and Washington, USA)
78. SPECT (Single photon emission computed tomography) in paediatrics - C. Chiron
(Paris, France)
79. Functional imaging: PET - A. Kumar and H.T. Chugani (Detroit, USA)
80. Advanced structural and functional MRI in childhood epilepsies - L. Hertz-Pannier,
S. Rodrigo and C. Chiron (Paris and Gif sur Yvette, France)
81. Paediatric epilepsy surgery - G. Dorfmüller and O. Delalande
(Paris, France)
82. Cognitive outcome of surgery - A. Gallagher, I. Jambaqué and
M. Lassonde (Boston, US; Paris, France and Montreal, Canada)
83. Nonpharmacologic approaches: diet and neurostimulation - E.H. Kossoff (Baltimore,
USA)
84. Outcome of paediatric epilepsies in adulthood - I. Gourfinkel-An and F.
Dubeau (Paris, France and Montreal, Canada)
Fax91 448 21 88
DirC / Raimundo Lulio, 1, 28010 Madrid, España.
Mailpedidosweb@axon.esPrivacidadCondiciones de ventaQuiénes SomosAvisoContacto© 2021 Axón Librería S.L.
v1.47.1